This inventor holds 1 USPTO granted patent and 2 published patent applications and 2 EPO patents. Top assignees: Beijing Tiantan Hospital, Capital Medical University, Nanjing Baixinyu Pharmaceutical Co. Ltd.. Active years: 2024.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2024
Title: Yilong Wang: Innovator in Pharmaceutical Composition
Introduction
Yilong Wang is a notable inventor based in Beijing, China. He has made significant contributions to the field of pharmaceuticals, particularly with his innovative work on edaravone compositions. His research and inventions have the potential to impact the medical community positively.
Latest Patents
Yilong Wang holds a patent for an edaravone pharmaceutical composition. This invention discloses a sublingual preparation that contains edaravone or a salt thereof along with mannitol. The sublingual administration method can effectively avoid the first-pass effect of the liver, providing advantages such as good stability and convenience of transport and use. This innovation represents a significant advancement in the delivery of edaravone.
Career Highlights
Throughout his career, Yilong Wang has worked with several esteemed institutions. He has been associated with Beijing Tiantan Hospital and Capital Medical University, where he has contributed to various research initiatives. Additionally, he has worked with Nanjing Baixinyu Pharmaceutical Co. Ltd., further enhancing his expertise in the pharmaceutical industry.
Collaborations
Yilong Wang has collaborated with notable colleagues, including Yongjun Wang and Xingquan Zhao. Their combined efforts have contributed to advancements in pharmaceutical research and development.
Conclusion
Yilong Wang's innovative work in the field of pharmaceuticals, particularly with his edaravone composition, showcases his dedication to improving medical treatments. His contributions are valuable to the ongoing development of effective pharmaceutical solutions.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile